Rituximab in the treatment of autoimmune haematological ...Rituximab in the treatment of autoimmune haematological disorders Bernadette Garvey St Michael’s Hospital, University of Toronto, Toronto, ON, Canada
Sun, 01 Mar 2015 13:31:00 GMT
Rituximab and other antibodies in the treatment of lymphoma4/8 Rituximab and other antibodies for lymphoma LYM0039/Ritux&antibodies/2014v2 Chronic lymphocytic leukaemia Rituximab can be used as part of the initial treatment ...
Mon, 02 Mar 2015 19:56:00 GMT
Interim Clinical Commissioning Policy Statement: Rituximab ...1 Interim Clinical Commissioning Policy Statement: Rituximab for the treatment of Systemic Lupus Erythematosus in adults September 2013 Reference: NHS ENGLAND
Mon, 02 Mar 2015 06:56:00 GMT
ATIENT INFORMATION ON RITUXIMAB - Rheumatologyrituximab 4 Australian Rheumatology Association www.rheumatology.org.au Revised March 2014 Surgery Rituximab treatment may be delayed if
Sat, 28 Feb 2015 01:43:00 GMT
Rituximab in the Treatment of Refractory Adult and ...out, with only 5 patients having a baseline visit and no subsequent measures. Table 1 summarizes the baseline demographic features of the 2 treatment groups.
Mon, 02 Mar 2015 14:48:00 GMT
Rituximab (Rituxan®) About Rituximab - Cancer Resources ...Rituximab (Rituxan®) Pronounced: ri-TUX-i-mab Classification: Monoclonal Antibody About Rituximab Rituximab is a synthetic (man made) antibody directed against a ...
Tue, 03 Mar 2015 18:00:00 GMT
DRUG NAME: Rituximab - BC Cancer AgencyRituximab BC Cancer Agency Cancer Drug Manual© Page 1 of 10 Rituximab Developed: 1 December 2012 Revised: 1 August 2014, 1 September 2014 DRUG NAME: Rituximab
Sun, 01 Mar 2015 21:45:00 GMT
Rituximab versus Cyclophosphamide for ANCA -Associated ...Rituximab vs. Cyclophosphamide in Vasculitis n engl j med 363;3 nejm.org july 15, 2010 223 (Rituxan, Genentech) (at a dose of 375 mg per square meter of ...
Sun, 01 Mar 2015 05:17:00 GMT
rituximab, 100mg in 10mL, 500mg in 50mL, concentrate for ...2 Indication Rituximab maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. Dosing Information
Mon, 02 Mar 2015 18:52:00 GMT
BCCA Protocol Summary for Treatment of Lymphoma with ...Patients with relapsed aggressive B-cell non-Hodgkin's lymphomas with good performance status who have been off treatment with riTUXimab for more than 3 months and ...
Tue, 03 Mar 2015 13:07:00 GMT